Amarin Corp Plc (AMRN)

[Ajax133]

New drug approvals in U.S. highest in 18 years
Biotech and pharmaceutical firms bounced back from patent losses and regained the ability to get new drugs into the market in 2014, as evidenced by the record number of approved drugs in the U.S. and higher number of approval recommendations in Europe. The FDA cleared 41 drugs in 2014, which is the highest number in 18 years and up 14 from 2013. In Europe, a total of 82 new drugs, including generics, were endorsed for approval

If it's the FDA as culprit, how does one explain the above. It
is obvious that FDA has always held grudges, and unfortunately
AMRN has been in their crosshairs. WHY ???